ROCO
4116
Market cap65mUSD
Nov 13, Last price
45.70TWD
Name
BenQ Medical Technology Corp
Chart & Performance
P/E
19.43
P/S
0.43
EPS
2.35
Div Yield, %
4.38%
Shrs. gr., 5y
-0.20%
Rev. gr., 5y
28.13%
Revenues
4.77b
+4.90%
Net income
105m
-8.51%
CFO
222m
-49.76%
Dividend
Jun 27, 20242 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BenQ Medical Technology Corporation engages in the manufacture, assembly, maintenance, repair, wholesale, retail, leasing, and sale of medical equipment and consumables in Taiwan, Mainland China, India, and internationally. The company offers operating tables, surgical lights, ultrasound systems, medical and protective masks, medical display monitors, and IQOR integrated systems. It is also involved in the wholesaling and retailing of information software; sale of medical drugs; management consultation services; and trading business. The company was formerly known as Trident Medical Corp. and changed its name to BenQ Medical Technology Corporation in June 2011. BenQ Medical Technology Corporation was incorporated in 1989 and is headquartered in Taipei, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||